China's chemical generic drug market size, China's medical insurance expenditure, and global innovative drug transactions

Consistency evaluation and centralized procurement have facilitated the advancement of CG reducing medical costs. CG that has passed consistency evaluation now extensively cover various therapeutic areas, with those in the antineoplastic field showing rapid expansion and becoming a key focus in drug research. The broad range of therapeutic applications and dosage forms for CG reflects the advancements in domestic drug research, development, and production, especially in the fields of anti-cancer drugs and complex formulations. The implementation of policies such as consistency evaluation and centralized procurement for CG significantly influences the improvement of drug quality assessment and the reduction of healthcare costs in China.